Edition:
United States

Venn Life Sciences Holdings PLC (VENN.L)

VENN.L on London Stock Exchange

14.83GBp
9:25am EDT
Change (% chg)

-0.05 (-0.30%)
Prev Close
14.88
Open
14.88
Day's High
--
Day's Low
--
Volume
144,500
Avg. Vol
131,513
52-wk High
30.30
52-wk Low
14.55

Latest Key Developments (Source: Significant Developments)

Venn Life Sciences contracts worth 3.4 mln euros signed with US Biotech
Tuesday, 12 Jan 2016 02:00am EST 

Venn Life Sciences:Says that they have signed new contracts worth over 3.4 mln euros with a US based Biotechnology client.Says these contracts are extensions of an existing Phase II programme.Says work will commence immediately and run until the end of 2017 in multiple US and European sites.  Full Article

Venn Life Sciences Holdings PLC announces contract for over EUR1 mln with French Biotech
Friday, 23 Oct 2015 02:00am EDT 

Venn Life Sciences Holdings PLC:Announces the signing of a project worth in excess of e1m with a French Biotech company.  Full Article

Venn Life Sciences Holdings PLC announces completion of acquisition of Kinesis Pharma BV
Monday, 19 Oct 2015 02:00am EDT 

Venn Life Sciences Holdings PLC:Announces the completion of the acquisition of Kinesis Pharma BV.  Full Article

Venn Life Sciences Holdings PLC Proposed acquisition of Kinesis Pharma BV
Tuesday, 22 Sep 2015 02:01am EDT 

Venn Life Sciences Holdings PLC:Says it has entered into an agreement to acquire the entire issued share capital of Kinesis Pharma BV, a provider of specialist consultancy services around the chemical-pharmaceutical, non-clinical and early clinical development of drug products.Says acquisition for a total maximum consideration of up to e6.5 mln.  Full Article

Venn Life Sciences Holdings Plc appoints CFO
Monday, 15 Jun 2015 02:00am EDT 

Venn Life Sciences Holdings Plc:Appointment of Jonathan Hartshorn as Chief Financial Officer with effect from June 15.Confirm that Jonathan will begin his duties in that role today.  Full Article

More From Around the Web